Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
European Radiology|June 12, 2021
Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinomaIlaria Vicentin, Cristina Mosconi, Enrico Garanzini, et al.
Cancer Treatment Reviews|March 9, 2025
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic reviewEdoardogregorio Galli, Giorgio Patelli, Federica Villa, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative SurgeryLeonardo Centonze, Riccardo De Carlis, Ivan Vella, et al.
European Journal of Radiology|December 11, 2025
MRI‑based scoring system to predict spondylodiscitis: The SPONDY-ScoreDomenico Albano, Caterina Beatrice Monti, Giulia Blanda, et al.
Cancers|June 24, 2022
Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and SurgeryValerio Nardone, Alfonso Reginelli, Roberta Grassi, et al.
World Journal of Surgical Oncology|March 30, 2023
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case reportGianluca Mauri, Viviana Gori, Giorgio Patelli, et al.
European Urology Open Science|March 10, 2022
Retzius-sparing Robot-assisted Radical Prostatectomy in High-risk Prostate Cancer Patients: Results from a Large Single-institution SeriesPaolo Dell'Oglio, Stefano Tappero, Mattia Longoni, et al.
Tumori|February 25, 2021
MRI only in a patient with prostate cancer with bilateral metal hip prostheses: case studyMarco Felisi, Angelo Filippo Monti, Domenico Lizio, et al.
International Journal of Cancer|September 3, 2020
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapyValentina Giannini, Samanta Rosati, Arianna Defeudis, et al.
Pageof 12